On Saturday morning, more than a dozen people led by Chen Cang gathered in the discussion room.


    Xu Ziming, director of cardiac surgery, is reporting the situation.


    "We analyzed the efficacy, safety and other indicators of patients undergoing phase I surgery, and the results showed that..."


    "The average operation time consumption of our team is about 5 minutes less than that of the current mainstream operation, but if Mr. Chen operates, it may save more time, but... This can not be used for the results of our clinical analysis."


    "From the perspective of efficacy analysis and safety, the efficacy is still determined by the surgical effect, which has reached the level reported at the 2019 world great blood vessel conference."


    "Safety... There are two main aspects. The first is mortality, and the second is complications. Because our inclusion criteria are relatively strict, we have not started the research on mortality yet, mainly focusing on complications."


    "The probability of complications is lower than that in 2019 because of our efforts in operation time."


    After Xu Ziming''s data came out, everyone on the scene couldn''t help cheering for it!


    After all, their efforts were not wasted.


    This data means that they are ready for clinical surgery.


    They have reached the current national average.


    Even Chen Cang was really happy.


    He couldn''t help applauding and gave the applause to their team members.


    Up to now, Chen Cang has not done everything himself.


    Instead, he is helping their team members and taking them to surgery.


    Because a person''s ability is limited after all.


    So far, among the first group of 12 people, 56 have been able to complete the operation, including Li Baoshan, Xu Ziming, he Zhiqian, Liu Quan and others.


    They are the first backbone!


    Progress is fast.


    However, what makes Chen Cang most curious is Xu Aiqing. She is the most hardworking and making the fastest progress in the team at present.


    For the sake of the children, Xu AI is really working hard.


    Everyone is very happy and excited.


    Their success means saving more patients.


    But


    The end of the first stage of surgery immediately means the beginning of a new stage.


    Xu Ziming said at this time, "Mr. Chen, how do you plan to carry out the second phase of cases?"


    The room was quiet at this time.


    In the first phase, they were carried out according to strict requirements and inclusion criteria, and achieved remarkable results.


    What about phase two?


    How to develop?


    After pondering for a moment, Chen Cang said faintly, "phase II, let go of the inclusion criteria and do mortality research!"


    As soon as the words came out, the surroundings became quiet.


    Mortality study!


    Everyone can''t help shaking.


    Mortality research has always been a field that no discipline is willing to touch.


    What we call efficiency now is not really efficiency.


    And how to incorporate standards efficiently.


    This is an inaccurate data.


    The real release of samples and the substantial release of inclusion criteria are the real data to study cases.


    In fact, life is much more cruel than data.


    Such as the study of mortality.


    This is completely liberalizing the inclusion criteria of cases to study mortality.


    Thinking of this, everyone couldn''t help looking at Chen Cang.


    Is this... Too hasty?


    After all, the first phase laid such a good foundation... Isn''t it... It''s a pity that it was ruined!


    Everyone feels a little distressed when they think of it.


    Because once the inclusion criteria are released and 100 cases are analyzed for efficacy and sequelae, it is obvious that it will be lower than the data in the first phase.


    Both safety and efficiency should be reduced!


    This is a good start. Do you really want to be beaten?


    Everyone was a little uneasy and uneasy.


    Xu Ziming couldn''t help saying, "Mr. Chen... Isn''t it a pity!"


    "No matter who we give such good results in the first phase, we will certainly carry out follow-up improvement research to further improve the efficiency and safety and reduce complications. In this way, our data..."


    Chen Cang did not change his face and asked faintly, "what''s the use of the data we want? It''s useless no matter how good these data are!"


    "We originally set up a project to study. Our purpose should not only be to get a beautiful clinical data?"


    "Our core goal is still to save people!"


    Everyone was silent.


    Chen Cang is right, but... Still a little unwilling.


    Everyone is doing this, and we can do the same!


    After all... There is a difference between clinical trials and real surgery.


    We can''t exclude the patient because he doesn''t meet the inclusion criteria and don''t operate on him.


    In this case, there is no point in our scientific research.


    But


    People just feel a little pity.


    Think about anzhen and Ruijin.


    Their emergency center also wants to have a good characteristic department, a top department famous all over the country and the world.


    However, this is not a day or two after all.


    Now, the clinical research on thoracoabdominal aortic replacement in patients with Ma fan is very research. Once the results come out, it is obvious that it can win an award!


    But


    Chen Cang''s unexpected operation made the whole team feel sorry.


    To tell the truth, if Chen Cang doesn''t change his policy and direction, he can get the award if he finishes the operation original!


    Hey


    Everyone couldn''t help sighing.


    "Mr. Chen, we... I still think we should improve the efficiency. After all, we have gone so far. Now we release the inclusion criteria at once, and the mortality and complication rates will rise at once. It is difficult for us to reduce these factors!" he Zhiqian also wants to fight for it.


    Chen Cang suddenly smiled: "can''t we let go of the inclusion criteria and talk about the treatment rate? Or can''t we let go of the inclusion criteria to study the probability of complications? Moreover, it can also include mortality!"


    "In this case, the proportion will be greatly reduced!" Xu Ziming couldn''t help saying.


    Chen Cang shook his head: "this data will be more real, more applicable to ordinary patients, and the greater the help to the medical field."


    "Moreover, who says that our proportion will be reduced?"


    This sentence confused everyone!


    This must be lower!


    If the inclusion criteria are released, the risk coefficient of patients will be greatly improved. The most dangerous thing of Marfan syndrome is sudden rupture of large blood vessels and death on the operating table.


    But what did Mr. Chen mean just now?


    Is it


    Has Mr. Chen found a better way?